Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CS MEDICA A/S: CEO Lone Henriksen buys shares in the Company

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CEO of the Company, Lone Henriksen, has acquired 4 974 shares in CS MEDICA through several transactions at an average price of 8,888, amounting to a total value of 44 209 DKK.CEO of CS MEDICA, Lone Henriksen, has purchased 4 974 shares in the open market at an average price of DKK 8,888 per share, corresponding to a total purchase of 44 209 DKK. The transactions have been disclosed to the Danish financial supervisory register. Following the transaction, Lone owns 4 077 551 CS MEDICA shares.

ColdZyme also blocks omicron variants BA.4 and BA.5

A new study by the Medical University of Innsbruck (MUI) shows that ColdZyme protects airway epithelia from infection with the widespread omicron variants BA.4 and BA.5. This builds upon previous research by the same research group, showing that ColdZyme blocks the original omicron BA.1 variant, which was communicated by Enzymatica in June 2022. The new study is due for publication within the coming months. ColdZyme has now been shown to block 11 respiratory tract viruses and viral sub-variants, including three omicron variants and other coronaviruses. The research group in Innsbruck

Repurchase of NCC Series B shares in week 32, 2022

During the period August 8 – August 12, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 287,147 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

InDex Pharmaceuticals announces successful interactions with the PMDA for the clinical development of cobitolimod in Japan

16 August, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that the company has received positive feedback from the Japanese regulatory authority, the Pharmaceuticals and Medical Devices Agency (PMDA), regarding the clinical development plan for a future marketing authorization application for the company's TLR9 agonist cobitolimod, for the treatment of moderate to severe left-sided ulcerative colitis. The PMDA has accepted enrolment of Japanese ulcerative colitis patients in the second global phase III induction study, without performing specific Japanese studies prior to

Peafowl Plasmonics strengthens production capacity

Peafowl Plasmonics takes the next step to secure production development and capacity by hiring Jonathan Ahlbom as COO.Jonathan has an extensive background in product development and production processes. Most recently he comes from Furhat Robotics, but he also has an entrepreneurial background as founder of several companies. “I’m totally convinced that Jonathan, with his background, has lots to contribute when we now enter the phase of optimizing and refining our production process,” says Per Edström, CEO at Peafowl. “With his experience in production, and as an entrepreneur himself, he

Heat: the forgotten word in renewable energy

An event to put the biggest problem in the energy transition on the map. Our modern world needs heat more than anything else, but we never talk about it. We’re changing that Wednesday 17th of August at 08:30 am on the boat Brim Explorer at Arendalsuka.Put your finger on something made without heat, we dare you! While the transport sector uses 35% of all energy, the production of heat for any purpose consumes half of all energy used by humans. Half! And almost entirely produced from fossil sources, resulting in 40% of the total CO2 emission. If you have a material and want to turn it into

Invitation to presentation of the quarterly report for Q2 2022

On Friday, August 19, at 1:00 pm, the quarterly report for Cabonline Group Holding AB (publ) (the "Company") for the period April – June 2022 will be published. In addition, there will be an opportunity for analysts and bond investors for presentation meetings on Monday, August 22 2022.Cabonline's CEO Dag Kibsgaard-Petersen and CFO Fredrik Lundqvist are available for digital meetings with analysts and bond investors on Monday, August 22. To book a meeting, please contact Aase Livbom, Pareto Securities; events.se@paretosec.com or +46 8 402 51 04. For further information, please contact:

GF Piping Systems at SMM 2022: Efficient and sustainable plastic piping systems for the marine industry

SMM in Hamburg, the leading international trade fair for the maritime industry, is focusing on topics such as digital transformation, climate change, and energy transition in 2022. From September 6 to 9, GF Piping Systems will present complete solutions that make shipping more sustainable.International shipping is facing a challenge: On the one hand it must comply with ever more stringent sustainability guidelines defined by the International Maritime Organization (IMO). At the same time, trends such as digitalization and automation have led to much higher technical demands on board.

Optomed’s Board has resolved upon a new option plan

Optomed Plc Stock Exchange Release 16 August 2022 at 11.00, Helsinki Optomed’s Board has resolved upon a new option plan Optomed’s board of directors has resolved upon a new option plan. The resolution is based on the authorization given by the general meeting of 10 May 2022.   Option plan 2022A: The total number of options is 250,000 and each option entitled to one share of the company. The options are offered to certain key employees. The purpose of the plan is to retain and incentifize key employees.  The subscription price is EUR 4.17 corresponding the closing price of 12

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 154 - 16 AUGUST 2022  In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 117/2022.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

Wärtsilä power plant upgrade and extension will enable production expansion for largest gold mine in Senegal

Wärtsilä Corporation, Press release, 16 August 2022 at 10:30 AM EESTThe technology group Wärtsilä will supply an 18 MW extension to the power generating facility and upgrade the electrical and automation system of the existing power plant at the Sabodala-Massawa gold mine complex in Senegal, West Africa. The mine is owned by Endeavour Mining, a leading global gold producer. The upgrading and extension project will allow for the complete integration of all the site’s power generating capacity, while ensuring the availability of the needed electric power to maintain and expand the mine’s

Safeture partnering with Falck Global Assistance & Aeger Group wins agreement with Innovation Norway

Safeture in partnership with Falck Global Assistance & Aeger Group has secured a two-year public procurement agreement regarding employee safety and travel risk management for Innovation Norway.Established in 2004, Innovation Norway is a state-owned company that offers capital, programs, and services to strengthen and stimulate entrepreneurship, innovation, and sustainable growth for Norwegian businesses and industry. Headquartered in Oslo, Norway, Innovation Norway has more than 700 employees in eleven counties in Norway and more than 30 countries worldwide. Together with its partner,

Contracts for AHTS’s in Norway and Brazil

Solstad Offshore ASA is pleased to announce that Equinor has declared an option to extend the contract for AHTS Normand Ferking with one more year to November 2023. Equinor has the option to extend the contract with further one year thereafter. Normand Ferking has been on contract with Equinor since 2007 and will continue to support their activities on the Norwegian Continental Shelf. In addition, AHTS Normand Topazio has been fixed to Enauta Energia S.A in Brazil.for 300 days firm plus 220 days of options. Commencement of the contract is 3Q-2022, and the vessel will support Enauta’s

Investor presentations for FluoGuide in H2 2022

Copenhagen, Denmark, 16 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that Morten Albrechtsen, CEO of FluoGuide will present FluoGuide at the following Investor meetings in H2 2022:· 7-8 September, Pareto Securities 13[th] Annual Heath Care Conference, Stockholm · 15 September, Redeye Investor AW, Malmö · 26 October, Redeye theme event, Stockholm · 21-23 November, SEB Healthcare seminar, Stockholm · 24 November, Redeye Life Science Day, Stockholm More information is available on https://fluoguide.com/investor/calendar-events/

Viaplay’s latest investment in Danish original content is ‘Call Me Dad’

· Alex Høgh Andersen (‘Vikings’), Magnus Haugaard (‘Guilt’) and Ellen Hillingsø (‘The Bridge’) headline Danish comedy-drama · ‘Call Me Dad’ produced by Nordisk Film Series · Viaplay to premiere at least 70 Originals in 2022 Viaplay’s next Danish Viaplay Original is the comedy-drama ‘Call Me Dad’, starring top local talents Alex Høgh Andersen (‘Vikings’), Magnus Haugaard (‘Guilt’) and Ellen Hillingsø (‘The Bridge’). Produced by Nordisk Film Series, written by Søren Felbo (‘Sunday’) and directed by Christian Dyekjær (‘Guru’), the six-part show joins Viaplay’s pipeline of Danish

NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF OPTOMED PLC

Optomed Plc         Stock Exchange Release    16 August 2022 at 10.00 Helsinki NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF OPTOMED PLC Notice is given to the shareholders of Optomed Plc (“Optomed” or the “Company”) of the Extraordinary General Meeting (the “General Meeting”) to be held on Tuesday, 6 September 2022 at 10:00 a.m. (EEST) at Life Science Center Keilaniemi, Keilaranta 16 B, FI-02150 Espoo, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 9:30 a.m. (EEST). A. Matters on the agenda of the

VTT spins out Olefy to revolutionize circular plastic recycling

After four decades of thermal conversion technology development, VTT is spinning out Olefy technology in October – a process that can affordably convert most of the world’s waste plastics back to usable virgin grade materials an infinite number of times. VTT also announces eight patent applications for the process.VTT has announced its plan to spin out a new company – Olefy Technologies . Its patent-pending technology can extract over 70% virgin grade plastics and chemical raw materials components from plastic waste. The new process can be done in a single step,

DanCann Pharma A/S appoints Charlotte Hagedorn Jørgensen as new Head of Quality Assurance

COPENHAGEN, Denmark, 16 August 2022 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) is pleased to announce the employment of Charlotte Hagedorn Jørgensen as Head of Quality Assurance at DanCann Pharma A/S.Charlotte Hagedorn Jørgensen joins the DanCann Pharma team as the Company’s Head of Quality Assurance. She is an experienced quality management professional and will oversee implementing relevant quality systems according to global standards such as GMP and GDP. Charlotte Hagedorn Jørgensen has a proven track record within Quality Assurance and joins DanCann Pharma

Stayble Therapeutics publishes half-year report for 2022

Stayble Therapeutics AB ("Stayble" or the "Company") hereby publishes the half-year report for 2022. The report is available as an attached document and on the Company's website.Highlights during the second quarter (April – June 2022) · Stayble announces that it has enrolled 75% of all patients in the ongoing Phase IIb clinical trial. Multiple efforts to increase patient enrollment coupled with the reduced impact of the Covid-19 pandemic have resulted in a significant increase in recruitment rates. The recruitment rate is in line with the set timeline and the final target to enroll all

MPC Energy Solutions reports on Q2 2022 results

Amsterdam/Oslo – 16 August 2022 – MPC Energy Solutions N.V. (“MPCES” or “Company”), Amsterdam, will publish its Q2 2022 report tomorrow morning. The Company develops, builds, owns and operates renewable energy projects including solar PV, wind, hybrid and energy efficiency solutions in Latin America and Caribbean. “We are happy to conclude another quarter of progress. The key milestone in the second quarter was the start of early works for the combined solar plant and battery energy storage system in St. Kitts. Once operational, this landmark project will be a key energy source for the

Scale Computing and Avassa Enter Partnership to Provide Dynamic Containerized Edge Environments

INDIANAPOLIS, USA. and STOCKHOLM, SWE. Scale Computing, a market leader in edge computing, virtualization, and hyperconverged solutions, and Avassa, a provider of an application-centric edge orchestration platform, announced today that they have entered into a partnership to offer a complete full-stack solution for edge environmentsScale Computing edge solutions are designed to provide customers with an autonomous infrastructure that can run modern containerized applications alongside legacy applications as virtual machines. This can help users centrally monitor and manage their fleet of

Ahlsell Danmark ApS announces extension of the offer period for its public offer for the shares in Sanistål A/S

Ahlsell Danmark ApS has decided to extend the offer period for its public offer for the shares held by ordinary shareholders in Sanistål A/S as regulatory approvals are still pending Ahlsell Denmark ApS will extend the offer period until 6 September 2022 at 17:00 (CET)In accordance with section 5.2 of the offer document dated 7 June 2022, Ahlsell Danmark ApS hereby announces its decision to extend the offer period until 6 September 2022 at 17:00 (CET). The decision is based on necessary regulatory approvals still being pending. Through purchases made during the offer period, Ahlsell

BioStock: Arcede wants to renew the market for respiratory drugs

Respiratorius spinoff Arcede Pharma is currently in full swing with the preclinical work on the drug candidate RCD405. The company hopes to be able to offer a new, better treatment for COPD and severe asthma than those offered to patients today. BioStock has taken a look at the current treatment landscape to get an understanding of the potential of a drug with a new mode of action.Read the full article at biostock.se:https://www.biostock.se/en/2022/08/arcede-wants-to-renew-the-market-for-respiratory-drugs/This is a press release from BioStock - Connecting Innovation & Capital. https://

Sectra launches next generation cloud portal to enhance clinical learning in medical education

Linköping, Sweden – August 16, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) launches a new generation of its cloud-based teaching platform Sectra Education Portal. It will greatly enhance students’ learning outside the classroom with significant improvements in usability and functionality. Aligned with Sectra’s overall commitment to deliver cloud-first software, it will facilitate for the hundreds of medical schools using the platform to bridge the gap between education and their students’ professional careers.“We want to give

There are no items matching the current filter
There are no more items matching the current filter
Back to top